Detalhe da pesquisa
1.
The association of serum interleukin-6 levels with clinical outcomes in antineutrophil cytoplasmic antibody-associated vasculitis.
J Autoimmun
; 105: 102302, 2019 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-31320177
2.
The net effect of ANCA on neutrophil extracellular trap formation.
Kidney Int
; 94(1): 14-16, 2018 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-29933842
3.
Towards precision medicine in ANCA-associated vasculitis.
Rheumatology (Oxford)
; 57(8): 1332-1339, 2018 08 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29045715
4.
Pharmacokinetics of rituximab and clinical outcomes in patients with anti-neutrophil cytoplasmic antibody associated vasculitis.
Rheumatology (Oxford)
; 57(4): 639-650, 2018 04 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29340623
5.
Proteome-wide analysis and CXCL4 as a biomarker in systemic sclerosis.
N Engl J Med
; 370(5): 433-43, 2014 Jan 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-24350901
6.
FSAP-mediated nucleosome release from late apoptotic cells is inhibited by autoantibodies present in SLE.
Eur J Immunol
; 46(3): 762-71, 2016 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-26626052
7.
Interstitial Immunostaining and Renal Outcomes in Antineutrophil Cytoplasmic Antibody-Associated Glomerulonephritis.
Am J Nephrol
; 46(3): 231-238, 2017.
Artigo
em Inglês
| MEDLINE | ID: mdl-28881339
8.
Ig gene analysis reveals altered selective pressures on Ig-producing cells in parotid glands of primary Sjögren's syndrome patients.
J Immunol
; 194(2): 514-21, 2015 Jan 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-25488989
9.
Usefulness of antineutrophil cytoplasmic autoantibodies in diagnosing and managing systemic vasculitis.
Curr Opin Rheumatol
; 28(1): 8-14, 2016 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-26599378
10.
Efficacy of remission-induction regimens for ANCA-associated vasculitis.
N Engl J Med
; 369(5): 417-27, 2013 Aug 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-23902481
11.
Using Mass Spectrometry to Quantify Rituximab and Perform Individualized Immunoglobulin Phenotyping in ANCA-Associated Vasculitis.
Anal Chem
; 88(12): 6317-25, 2016 06 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-27228216
12.
Toll-like receptor 9 activation enhances B cell activating factor and interleukin-21 induced anti-proteinase 3 autoantibody production in vitro.
Rheumatology (Oxford)
; 55(1): 162-72, 2016 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-26320128
13.
Pro: Cyclophosphamide in lupus nephritis.
Nephrol Dial Transplant
; 31(7): 1047-52, 2016 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-27190359
14.
Extended versus standard azathioprine maintenance therapy in newly diagnosed proteinase-3 anti-neutrophil cytoplasmic antibody-associated vasculitis patients who remain cytoplasmic anti-neutrophil cytoplasmic antibody-positive after induction of remission: a randomized clinical trial.
Nephrol Dial Transplant
; 31(9): 1453-9, 2016 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-27242368
15.
Rituximab versus cyclophosphamide for ANCA-associated vasculitis with renal involvement.
J Am Soc Nephrol
; 26(4): 976-85, 2015 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-25381429
16.
Does reduction of disease activity improve early markers of cardiovascular disease in newly diagnosed rheumatoid arthritis patients?
Rheumatology (Oxford)
; 54(7): 1257-61, 2015 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-25587178
17.
High mobility group box 1 serum levels are increased in Behçet's disease, but not associated with disease activity or disease manifestations.
Rheumatology (Oxford)
; 54(12): 2151-5, 2015 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-26170374
18.
B-cell therapy in antineutrophil cytoplasmic antibody-associated vasculitis.
Nephrol Dial Transplant
; 30 Suppl 1: i119-22, 2015 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-25753806
19.
Pathogenesis and treatment of ANCA-associated vasculitides.
Clin Exp Rheumatol
; 33(4 Suppl 92): S11-4, 2015.
Artigo
em Inglês
| MEDLINE | ID: mdl-26457917
20.
Is B-cell depletion first choice in antineutrophil cytoplasmic antibody-associated vasculitis?
Curr Opin Rheumatol
; 26(3): 292-8, 2014 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-24646946